User profiles for Jeffrey V Lazarus

Jeffrey V Lazarus

CUNY Graduate School of Public Health and Health Policy (CUNY SPH)
Verified email at isglobal.org
Cited by 68598

[HTML][HTML] A global survey of potential acceptance of a COVID-19 vaccine

JV Lazarus, SC Ratzan, A Palayew, LO Gostin… - Nature medicine, 2021 - nature.com
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June
2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates …

[HTML][HTML] The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations

JV Lazarus, K Safreed-Harmon… - Seminars in liver …, 2018 - thieme-connect.com
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

…, CL Wai-cheung, J Layden, JV Lazarus… - The lancet …, 2018 - thelancet.com
Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

[HTML][HTML] Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030

…, Y Eguchi, A Geier, LA Kondili, DC Kroy, JV Lazarus… - Journal of …, 2018 - Elsevier
Background & Aims Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis
(NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. …

Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies

…, H Cortez-Pinto, F Negro, E Corbould, JV Lazarus… - Journal of …, 2018 - Elsevier
The burden of liver disease in Europe continues to grow. We aimed to describe the epidemiology
of liver diseases and their risk factors in European countries, identifying public health …

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

…, J Howell, J Jia, N Kravchenko, JV Lazarus… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …

[HTML][HTML] COVID-SCORE: A global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)

JV Lazarus, S Ratzan, A Palayew, FC Billari… - PloS one, 2020 - journals.plos.org
Background Understanding public perceptions of government responses to COVID-19 may
foster improved public cooperation. Trust in government and population risk of exposure may …

[HTML][HTML] Pandemic publishing poses a new COVID-19 challenge

…, TH Andersen, LN Rasmussen, JV Lazarus - Nature Human …, 2020 - nature.com
The scientific community’s response to COVID-19 has resulted in a large volume of research
moving through the publication pipeline at extraordinary speed, with a median time from …

[HTML][HTML] The Lancet Commission on lessons for the future from the COVID-19 pandemic

…, M Hellard, UK Huynh, S Khandelwal, JV Lazarus… - The Lancet, 2022 - thelancet.com
As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2 million estimated
deaths from COVID-19, as reported by the Institute for Health Metrics and Evaluation (IHME; …

[HTML][HTML] Advancing the global public health agenda for NAFLD: a consensus statement

JV Lazarus, HE Mark, QM Anstee, JP Arab… - Nature Reviews …, 2022 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects
approximately one-quarter of the global adult population, causing a substantial burden of ill …